Tirzepatide is not a fixed-dose medication. A typical course starts at 2.5mg and steps up — 5, 7.5, 10, 12.5, sometimes 15mg — as your prescriber adjusts. The price at 2.5mg may tell you very little about what you will pay at a maintenance dose.
Two structures
Flat-rate providers charge the same at every dose. Dose-tiered providers charge more as the dose rises — a $199 starter can become $389+ at 12.5–15mg. Over a year on a higher dose, that compounds into hundreds or thousands of dollars.
What to check
Ask each provider directly: does the price change at higher doses? Get it in writing for the doses you are likely to reach, not just the starting dose. Some publish flat pricing, some publish per-dose pricing, many require you to ask. Treat a flat claim as something to verify, like any figure. If you expect to titrate to and stay at a higher dose, dose-escalation pricing is probably the most important number in your comparison.
If predictable, dose-independent pricing is what you are after, NexLife publishes a flat rate across the full 2.5–15mg range. It is not always the lowest entry price — a short, low-dose trial may cost less elsewhere.
See NexLife flat-rate plans →Commercial/provider link. Verify current pricing on NexLife's site.